• Je něco špatně v tomto záznamu ?

Long-term donors versus non-donor men: Iron metabolism and the atherosclerotic process

P. Riško, J. Pláteník, R. Buchal, J. Potočková, PJ. Kraml,

. 2018 ; 272 (-) : 14-20. [pub] 20180303

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045527

BACKGROUND AND AIMS: The increased iron level and the labile iron pool (LIP) in circulating monocytes are connected to a higher frequency of cardiovascular events. METHODS: The study investigates the relationship between LIP in circulating monocytes and markers of iron metabolism and atherosclerosis (inflammation, oxidative stress, endothelial dysfunction and arterial elasticity) in long-term blood donors and non-donor volunteers. RESULTS: We found that donors had significantly higher LIP values than the control group (1.89 ± 0.47 μM vs. 1.50 ± 0.41 μM, p = 0.007). Despite the observed tendency for the donor group to have higher blood pressure, cholesterol, glucose and HOMAR-IR (homeostasis model assessment of insulin resistance), the groups did not differ in inflammatory markers, markers of endothelial dysfunction and markers of impaired arterial elasticity. The donor group had significant changes in iron metabolism (higher serum Fe, ceruloplasmin, and TfR/Ft ratio (transferrin receptor/ferritin ratio) and lower hepcidin, ferritin, and CD163), indicating depletion of body iron stores and activation of iron turnover. CONCLUSIONS: LIP seems to be a good marker of iron turnover activity in these individuals despite the lack of a decrease in the hemoglobin concentration. We did not find a significant correlation between LIP levels and atherosclerosis progression in the two groups. However, further studies are needed to assess long-term donorship as a protective factor against atherosclerosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045527
003      
CZ-PrNML
005      
20200113083758.0
007      
ta
008      
200109s2018 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.atherosclerosis.2018.03.009 $2 doi
035    __
$a (PubMed)29544084
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Riško, Peter $u 2nd Department of Internal Medicine, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: riskopeter1985@gmail.com.
245    10
$a Long-term donors versus non-donor men: Iron metabolism and the atherosclerotic process / $c P. Riško, J. Pláteník, R. Buchal, J. Potočková, PJ. Kraml,
520    9_
$a BACKGROUND AND AIMS: The increased iron level and the labile iron pool (LIP) in circulating monocytes are connected to a higher frequency of cardiovascular events. METHODS: The study investigates the relationship between LIP in circulating monocytes and markers of iron metabolism and atherosclerosis (inflammation, oxidative stress, endothelial dysfunction and arterial elasticity) in long-term blood donors and non-donor volunteers. RESULTS: We found that donors had significantly higher LIP values than the control group (1.89 ± 0.47 μM vs. 1.50 ± 0.41 μM, p = 0.007). Despite the observed tendency for the donor group to have higher blood pressure, cholesterol, glucose and HOMAR-IR (homeostasis model assessment of insulin resistance), the groups did not differ in inflammatory markers, markers of endothelial dysfunction and markers of impaired arterial elasticity. The donor group had significant changes in iron metabolism (higher serum Fe, ceruloplasmin, and TfR/Ft ratio (transferrin receptor/ferritin ratio) and lower hepcidin, ferritin, and CD163), indicating depletion of body iron stores and activation of iron turnover. CONCLUSIONS: LIP seems to be a good marker of iron turnover activity in these individuals despite the lack of a decrease in the hemoglobin concentration. We did not find a significant correlation between LIP levels and atherosclerosis progression in the two groups. However, further studies are needed to assess long-term donorship as a protective factor against atherosclerosis.
650    _2
$a algoritmy $7 D000465
650    _2
$a ateroskleróza $x krev $7 D050197
650    12
$a dárci krve $7 D001782
650    _2
$a kardiovaskulární nemoci $x krev $7 D002318
650    _2
$a ceruloplasmin $x analýza $7 D002570
650    _2
$a cévní endotel $x patologie $7 D004730
650    _2
$a ferritiny $x krev $7 D005293
650    _2
$a hepcidiny $x krev $7 D064451
650    _2
$a lidé $7 D006801
650    _2
$a zánět $7 D007249
650    _2
$a inzulinová rezistence $7 D007333
650    _2
$a železo $x krev $x metabolismus $7 D007501
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a oxidační stres $7 D018384
650    _2
$a riziko $7 D012306
650    _2
$a rizikové faktory $7 D012307
650    _2
$a transferin $x analýza $7 D014168
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pláteník, Jan $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Buchal, Richard $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Potočková, Jana $u 2nd Department of Internal Medicine, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kraml, Pavel J $u 2nd Department of Internal Medicine, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00009284 $t Atherosclerosis $x 1879-1484 $g Roč. 272, č. - (2018), s. 14-20
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29544084 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113084130 $b ABA008
999    __
$a ok $b bmc $g 1483795 $s 1084200
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 272 $c - $d 14-20 $e 20180303 $i 1879-1484 $m Atherosclerosis $n Atherosclerosis $x MED00009284
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace